Salmon calcitonin reduces oxaliplatin-induced cold and mechanical allodynia in rats

Biological and Pharmaceutical Bulletin

Volumn 36, Issue 2, 2013, Pages 326-329

  Aoki, Manahito ^a   Mori, Asami ^a   Nakahara, Tsutomu ^a   Sakamoto, Kenji ^a   Ishii, Kunio ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Oxaliplatin; Peripheral neuropathy; Salmon calcitonin

Indexed keywords

SALCATONIN;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLD STRESS; CONTROLLED STUDY; DRUG MECHANISM; MALE; MECHANICAL STIMULATION; NONHUMAN; PERIPHERAL NEUROPATHY; RAT;

ANALGESICS; ANIMALS; CALCITONIN; COLD TEMPERATURE; HYPERALGESIA; MALE; ORGANOPLATINUM COMPOUNDS; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84874034742     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b12-00887     Document Type: Article

References (29)

1. McKeage MJ. Comparative adverse effect profiles of platinum drugs. Drug Saf., 13, 228-244 (1995).
2. Andre T, Boni C, Mounedji-Boudiaf L, Navarro M., Tabernero J, Hickish T, Topham C., Zaninelli M, Clingan P, Bridgewater J., Tabah-Fisch I, de Gramont A, Multicenter International Study of Oxaliplatin/5-Fluorouracil/leucovorin in the Adjuvant Treatment of Colon Cancer Investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. Engl. J. Med., 350, 2343-2351 (2004).
3. Pasetto LM, d'Andrea MR, Rossi E, Monfardini S. Oxaliplatinrelated neurotoxicity: how and why? Crit. Rev. Oncol./Hematol., 59, 159-168 (2006).
4. Marie PJ, Caulin F. Mechanisms underlying the effects of phosphate and calcitonin on bone histology in postmenopausal osteoporosis. Bone, 7, 17-22 (1986).
5. Gennari C, Agnusdei D, Gonnelli S. Calcitonin and bone pain. Osteoporosis: Physiological Basis, Assessment and Treatment. elsevier, New York, pp. 269-274 (1990).
6. Pun KK, Chan LW Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures. Clin. Ther., 11, 205-209 (1989).
7. Pontiroli AE, Pajetta E, Calderara A., Alberetto M, Pozza G, Manganelli V., Resmini G, Tessari L, Maresca V. Intranasal and intramuscular human calcitonin in female osteoporosis and in Paget's disease of bones: a pilot study. J. Endocrinol. Invest., 14, 47-51 (1991).
8. Fujita T. Therapy of osteoporosis in Japan. Osteoporosis 1990. Osteopress, Copenhagen, pp. 2107-2112 (1990).
9. Zieleniewski W. Calcitonin nasal spray for painful diabetic neuropathy. Lancet, 336, 449 (1990).
10. Gobelet C, Meier JL, Schaffner W, Bischof-Delaloye A, Gerster J.C., Burckhardt P. Calcitonin and reflex sympathetic dystrophy syndrome. Clin. Rheumatol., 5, 382-388 (1986).
11. Hamamci N, Dursun E, Ural C., Cakci A. Calcitonin treatment in reflex sympathetic dystrophy: a preliminary study. Br. J. Clin. Pract., 50, 373-375 (1996).
12. Ustdal M, Dogan P, Soyuer A., Terzi S. Treatment of migraine with salmon calcitonin: effects on plasma beta-endorphin, ACTh and cortisol levels. Biomed. Pharmacother., 43, 687-691 (1989).
13. Umeno H, Nagasawa T, Yamazaki N., Kuraishi Y. Antinociceptive effects of repeated systemic injections of calcitonin in formalin-induced hyperalgesic rats. Pharmacol. Biochem. Behav., 55, 151-156 (1996).
14. Aoki M, Mori A, Nakahara T., Sakamoto K, Ishii K. effect of synthetic eel calcitonin, elcatonin, on cold and mechanical allodynia induced by oxaliplatin and paclitaxel in rats. Eur. J. Pharmacol., 696, 62-69 (2012).
15. Ling B, Coudoré F, Decalonne L, Eschalier A, Authier N. Comparative antiallodynic activity of morphine, pregabalin and lidocaine in a rat model of neuropathic pain produced by one oxaliplatin injection. Neuropharmacology, 55, 724-728 (2008).
16. Li M, Shen Y, Burton K.W., Deluca PP, Mehta RC, Baumann BD, Wronski TJ A comparison of the skeletal effects of intermittent and continuous administration of calcitonin in ovariectomized rats. Bone, 18, 375-380 (1996).
17. Nassini R, Gees M, Harrison S., de Siena G, Materazzi S, Moretto N., Failli P, Preti D, Marchetti N., Cavazzini A, Mancini F, Pedretti P, Nilius B, Patacchini R, Geppetti P. Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation. Pain, 152, 1621-1631 (2011).
18. Gauchan P, Andoh T, Kato A., Kuraishi Y. Involvement of increased expression of transient receptor potential melastatin 8 in oxaliplatin-induced cold allodynia in mice. Neurosci. Lett., 458, 93-95 (2009).
19. 2+ channel blockers prevent oxaliplatin-induced cold hyperalgesia and TRPM8 overexpression in rats. Mol. Pain, 8, 7 (2012).
20. Sakurai M, Egashira N, Kawashiri T., Yano T, Ikesue H, Oishi R. Oxaliplatin-induced neuropathy in the rat: involvement of oxalate in cold hyperalgesia but not mechanical allodynia. Pain, 147, 165-174 (2009).
21. + channel kinetics on rat sensory neurons. Eur. J. Pharmacol., 406, 25-32 (2000).
22. Egashira N, Hirakawa S, Kawashiri T., Yano T, Ikesue H, Oishi R. Mexiletine reverses oxaliplatin-induced neuropathic pain in rats. J. Pharmacol. Sci., 112, 473-476 (2010).
23. Ling B, Authier N, Balayssac D., Eschalier A, Coudore F. Behavioral and pharmacological description of oxaliplatin-induced painful neuropathy in rat. Pain, 128, 225-234 (2007).
24. Yoshimura T, Ito A, Saito S.Y., Takeda M., Kuriyama H, Ishikawa T. Calcitonin ameliorates enhanced arterial contractility after chronic constriction injury of the sciatic nerve in rats. Fundam. Clin. Pharmacol., 26, 315-321 (2012).
25. Ito A, Takeda M, Yoshimura T., Komatsu T, Ohno T, Kuriyama H., Matsuda A, Yoshimura M. Anti-hyperalgesic effects of calcitonin on neuropathic pain interacting with its peripheral receptors. Mol. Pain, 8, 42 (2012).
26. 1 analog limaprost on mechanical allodynia caused by chemotherapeutic agents in mice. J. Pharmacol. Sci., 109, 469-472 (2009).
27. Yoshimura T, Ito A, Saito S.Y., Takeda M., Kuriyama H, Ishikawa T. Calcitonin ameliorates enhanced arterial contractility after chronic constriction injury of the sciatic nerve in rats. Fundam. Clin. Pharmacol., 26, 315-321 (2012).
28. Kounoe N. experimental study on enhancement of anticancer drug effects on the cultivated cancer cells: the effects of cisplatin in combination with caffeine and calcitonin on the cultivated KB cells. Kyushu-Shika-Gakkai-zasshi, 53, 101-110 (1999).
29. Yoneda T, Kuroda T. Inhibitor of cancer metastasis. Japan patent 4440412 (2010).